Fluorescence properties of fluorine-containing hydantoin derivatives as potential fluorescent probes

I.A. LYTVYN, O.V. KULYNYCH, V.S. STAROVA, P.K. MYKHAILIUK, O.A. ZAPOROZHETS

References:

1.      Trišović Nemanja P., Ušćumlić Gordana S., Petrović Slobodan D. Hydantoins: Synthesis, properties and anticonvulsant activity. Hemijska industrija. 2009, 63(1), 17-31.

2.     Aboul-Enein M.N.,  El-Azzouny A.A.,  Attia M.I.,  Maklad Y.A., et al. Anticonvulsant Profiles of Certain New 6-Aryl-9-substituted-6,9-diazaspiro-[4.5]decane-8,10-diones and 1-Aryl-4-substituted-1,4-diazaspiro[5.5]undecane-3,5-diones. Int. J. Mol. Sci. 2014, 15(9), 16911–16935.

3.      Rodgers T.R., LaMontagne M.P., Markovac A., Ash A.B. Hydantoins as antitumor agents. Journal of medicinal chemistry. 1977, 20(4), 591-594. 

4.      Shankaraiah N., Nekkanti S.,  Chudasama K.J.,  Senwar K.R., et al. Design, synthesis and anticancer evaluation of tetrahydro-β-carboline-hydantoin hybrids. Bioorganic and Medical Chemistry Letters. 2014, 24(23), 5413-5417.

5.    Mudit M., Behery F.A, Wali V.B, Sylvester P.W, El Sayed K.A. Synthesis of fluorescent analogues of the anticancer natural products 4-hydroxyphenylmethylene hydantoin and delta-tocotrienol. Nat. Prod. Commun. 2010, 5(10), 1623-1626.

6.      Beebe R., Myers J. Proffessional Paramedic: Foundations of Paramedic Care. Delmar, Cengage Learning, USA. 2010. P. 695.

7.    Morgenthaler M., Schweizer E., Hoffmann-Roeder A., et al. Predicting and tuning physicochemical properties in lead optimization: amine basicities. Chem. Med. Chem. 2007, 2 (8), 1100-1115.

8.     Shcherbatiuk A.V., Shyshlyk O.S., Yarmoliuk D.V., et al. Synthesis of 2- and 3-trifluoromethylmorpholines: useful building blocks for drug discovery. Tetrahedron. 2013, 69 (19), 3796-3804.

9.     Purser S., Moore P.R., Swallow S., Gouverneur V.  Fluorine in medicinal chemistry. Chem. Soc. Rev. 2008, 37, 320.

10.  Begue J.P., Bonnet-Delpon D., Wiley J., et al. Bioorganic and Medicinal Chemistry of Fluorine. New Jersey. 2008.

11.  Chaume G., Barbeau O., Lesot P., Brigaud T. Synthesis of 2-Trifluoromethyl-1,3-oxazolidines as Hydrolytically Stable Pseudoprolines. J. Org. Chem. 2010, 75, 4135-4145.

12.  Mykhailiuk P.K., Iurchenko V., Shishkina S.V.,  Shishkin O.V., et al.  1-Amino-4,4-difluorocyclohexanecarboxylic acid as a promising building block for drug discovery: design, synthesis and characterization. Tetrahedron. 2013, 69 (20), 4066-4075.

13.  Bretschneider, et al. Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy and halogen-substituted spirocyclic ketonols. United States Patent. 8,946,124. 2015.

14. Gerus I.I., Mironetz R.X., Kondratov I.S., Bezdudny A.V., et al.  “Reported, but still unknown.” A closer look into 3,4-bis- and 3,4,5-tris(trifluoromethyl)pyrazoles. The Journal of Organic Chemistry. 2012, 77 (1), 47-56.

15.  Britsun V.N., Doroshchuk V.A., Starova V.S., Ryabitskii A.B., Lozinskii M.O. Protolytic Properties of 2-Acylthioacetamides. Russian Journal of General Chemistry. 2012, 82 (10), 1700–1704.

16.  Brouwer A.M., Lakowicz J.R. Standards for photoluminescence quantum yield measurements in solution (IUPAC Technical Report). Pure Appl. Chem.  2011, 83 (12), 2213-2228. 

17.   Chen R.F. Fluorescence Quantum Yields of Tryptophan and Tyrosine. Analytical Letters. 1967, 1(1), 35-42.

18.   A guide to rrecording fluorescence quantum yields. Technical report, Horiba, Jobin Yvon Ltd, 2 Dalston Gardens, Stanmore, Middlesex, UK. 2011.

19.   Prevost G.,  Auvin S.,  Lanco C.,  Liberatore A.-M.,  Lavergne O.  Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug. Patent. US8710091 B2. 2014.

20.   Protsenko L.D., Bulkina Z.P. Chemistry and pharmacology of synthetic anticancer drugs. Directory. K .: "Scientific Opinion". 1985. 260 p. (in Russ.).